Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

505
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
505
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

423
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
423
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

590
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
590

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operating Room Access: Survey of the American Society of Retina Specialists.

Journal of vitreoretinal diseases·2026
Same author

Underfunding of a Patient Copay Assistance Program and the Impact on Retinal Disease Care: Survey of ASRS Members.

Journal of vitreoretinal diseases·2026
Same author

Real-World Utilization and Initial Experience with Aflibercept-ayyh (PAVBLU<sup>®</sup>) for Retinal Disorders in United States Retina Practices: A Descriptive Retrospective Analysis.

Ophthalmology and therapy·2026
Same author

The Hourglass Sign on Optical Coherence Tomography in Soccer-Related Blunt Ocular Trauma.

Journal of vitreoretinal diseases·2026
Same author

Clinical Outcomes of Ocular Toxoplasmosis-Associated Rhegmatogenous and Tractional Retinal Detachment.

Journal of vitreoretinal diseases·2026
Same author

Comparison of Medicaid vs Medicare Reimbursement Rates for Vitreoretinal Surgeries in the United States.

Journal of vitreoretinal diseases·2026

Related Experiment Video

Updated: Aug 4, 2025

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.3K

Intravitreal Injection Therapy: Current Techniques and Supplemental Services.

Linda A Lam1, Sonia Mehta2, Eleonora M Lad3

  • 1University of Southern California Roski Eye Institute, Keck School of Medicine, Los Angeles, CA, USA.

Journal of Vitreoretinal Diseases
|April 3, 2023
PubMed
Summary
This summary is machine-generated.

Intravitreal injections are crucial for treating retinal diseases. Tailoring treatment plans to individual patients enhances safety and improves therapeutic outcomes for better vision.

Keywords:
antivascular endothelial growth factor agentschoroidal neovascularizationdiabetic retinopathyinjection techniqueintravitreal injectionmedical decision-makingwet age-related macular degeneration (neovascular)

More Related Videos

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

261
Intravitreous Injection for Establishing Ocular Diseases Model
05:37

Intravitreous Injection for Establishing Ocular Diseases Model

Published on: October 1, 2007

36.9K

Related Experiment Videos

Last Updated: Aug 4, 2025

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.3K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

261
Intravitreous Injection for Establishing Ocular Diseases Model
05:37

Intravitreous Injection for Establishing Ocular Diseases Model

Published on: October 1, 2007

36.9K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Surgical Procedures

Background:

  • Intravitreal injection is the most common eye procedure globally.
  • It is essential for managing sight-threatening retinal conditions.
  • The procedure carries inherent risks requiring careful consideration.

Purpose of the Study:

  • To document the intricacies of the intravitreal injection procedure.
  • To outline the necessary components for successful treatment.
  • To guide retina specialists in managing complex cases.

Main Methods:

  • Expert consensus from the Intravitreal Injection Task Force Committee.
  • Documentation of procedure complexities and decision-making factors.
  • Review of patient history, examination, and diagnostic testing.

Main Results:

  • Recommendations for ancillary services and decision-making during intravitreal injection visits.
  • Guidance on monitoring treatment response and adjusting therapy.
  • Considerations for managing conditions in the treated or fellow eye.

Conclusions:

  • Individualized consideration and customization optimize intravitreal injection safety.
  • Tailored treatment plans lead to improved therapeutic outcomes.
  • Retina specialists play a key role in maximizing patient benefits.